Comparison of Effectiveness of Zinc Supplementation With ORS and Bacillus Clausii Versus Zinc With ORS and Saccharomyces Boulardii in Acute Watery Diarrhea in Paediatric Patients
NCT ID: NCT06540209
Last Updated: 2024-08-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2023-04-01
2023-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Zinc Plus Saccharomyces Boulardii Versus Zinc Alone in the Treatment of Acute Diarrhea
NCT07168304
Zinc-ORS in Severe and Complicated Acute Diarrhea
NCT00370968
Oral Rehydration Solution With Zinc and Prebiotics in Acute Diarrhea
NCT01025583
Zinc Sulfate Acceptability
NCT04039828
A Comprehensive Analysis of the Comparative Efficacy of Multimodal Diarrhea Therapies in the Paediatric Population
NCT06588036
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Bacillus clausii + zinc+ ORS group
Patients received zinc supplementation with ORS and Bacillus clausii
Bacillus clausii
Children will be give Bacillus clausii for 5 days
Zinc
Zinc will be given to all children for 5 days
ORS
ORS will be given to all children for 5 days
Saccharomyces boulardii +zinc+ ORS group
Patients were given zinc with ORS and Saccharomyces boulardii
Saccharomyces boulardii
Children will be give Saccharomyces boulardii for 5 days
Zinc
Zinc will be given to all children for 5 days
ORS
ORS will be given to all children for 5 days
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bacillus clausii
Children will be give Bacillus clausii for 5 days
Saccharomyces boulardii
Children will be give Saccharomyces boulardii for 5 days
Zinc
Zinc will be given to all children for 5 days
ORS
ORS will be given to all children for 5 days
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged 3 months to 5 years
* With acute watery diarrhea last less fewer than 14 days
* Presenting with mild to moderate dehydration
Exclusion Criteria
* History of recent antibiotic or probiotic treatment
* Patients with immunodeficiency conditions, acute systemic illnesses, or chronic diarrhea
* Patients with hypersensitivity to Bacillus clausii or Saccharomyces boulardii
3 Months
5 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
RESnTEC, Institute of Research
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Wajiha Rizwan, FCPS
Role: PRINCIPAL_INVESTIGATOR
University of Child Health Sciences, The Children's Hospital Lahore, Pakistan
Muhammad Tufail, MBBS
Role: PRINCIPAL_INVESTIGATOR
University of Child Health Sciences, The Children's Hospital Lahore, Pakistan
Azher Abbas Shah
Role: PRINCIPAL_INVESTIGATOR
University of Child Health Sciences, The Children's Hospital Lahore, Pakistan
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Child Health Sciences, The Children's Hospital
Lahore, Punjab Province, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AWD-CHLAHORE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.